Total Payments
$8,182
2024 Payments
$1,229
Companies
21
Transactions
293
Medicare Patients
247
Medicare Billing
$189,676
Payment Breakdown by Category
Food & Beverage$8,147 (99.6%)
Education$35.68 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,147 | 290 | 99.6% |
| Education | $35.68 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,357 | 83 | $0 (2024) |
| ABBVIE INC. | $1,075 | 60 | $0 (2024) |
| Alkermes, Inc. | $1,031 | 27 | $0 (2024) |
| ITI, Inc. | $551.11 | 9 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $539.17 | 27 | $0 (2022) |
| Allergan, Inc. | $527.31 | 18 | $0 (2020) |
| Lundbeck LLC | $389.55 | 24 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $237.19 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $208.75 | 12 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $207.06 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,229 | 41 | ABBVIE INC. ($323.03) |
| 2023 | $1,232 | 41 | Otsuka America Pharmaceutical, Inc. ($338.87) |
| 2022 | $1,144 | 57 | Otsuka America Pharmaceutical, Inc. ($360.26) |
| 2021 | $1,131 | 49 | ITI, Inc. ($418.92) |
| 2020 | $246.54 | 10 | Otsuka America Pharmaceutical, Inc. ($116.84) |
| 2019 | $1,219 | 27 | Otsuka America Pharmaceutical, Inc. ($331.24) |
| 2018 | $1,339 | 39 | Otsuka America Pharmaceutical, Inc. ($628.89) |
| 2017 | $642.57 | 29 | Allergan Inc. ($178.98) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: CNS | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $121.40 | General |
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CNS | ||||||
| 08/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: PSYCHIATRY | ||||||
| 04/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CNS | ||||||
| 04/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: PSYCHIATRY | ||||||
| 04/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 44 | 454 | $110,567 | $39,807 |
| 2022 | 4 | 73 | 626 | $137,074 | $51,360 |
| 2021 | 5 | 70 | 665 | $131,950 | $47,812 |
| 2020 | 4 | 60 | 736 | $147,393 | $50,697 |
Total Patients
247
Total Services
2,481
Medicare Billing
$189,676
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 204 | $35,799 | $19,610 | 54.8% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 13 | 161 | $48,420 | $14,352 | 29.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 15 | 89 | $26,349 | $5,845 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 202 | $34,906 | $18,913 | 54.2% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 15 | 179 | $51,780 | $16,125 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 122 | $18,807 | $8,205 | 43.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 20 | 123 | $31,581 | $8,118 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 218 | $36,958 | $17,056 | 46.1% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 11 | 186 | $51,150 | $15,615 | 30.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 16 | 126 | $23,295 | $7,546 | 32.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 118 | $17,983 | $6,701 | 37.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 11 | 17 | $2,565 | $893.55 | 34.8% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 14 | 233 | $63,636 | $20,819 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 244 | $37,157 | $11,500 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 134 | $23,658 | $9,734 | 41.1% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 16 | 125 | $22,942 | $8,644 | 37.7% |
About Dr. S. Kreps, M.D
Dr. S. Kreps, M.D is a Child & Adolescent Psychiatry healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689728321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. S. Kreps, M.D has received a total of $8,182 in payments from pharmaceutical and medical device companies, with $1,229 received in 2024. These payments were reported across 293 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,147).
As a Medicare-enrolled provider, Kreps has provided services to 247 Medicare beneficiaries, totaling 2,481 services with total Medicare billing of $189,676. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Pittsburgh, PA
- Active Since 01/22/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689728321
Products in Payments
- REXULTI (Drug) $1,799
- VRAYLAR (Drug) $1,603
- LYBALVI (Drug) $782.03
- CAPLYTA (Drug) $758.17
- ABILIFY MAINTENA (Drug) $650.26
- LATUDA (Drug) $539.17
- TRINTELLIX (Drug) $274.11
- ARISTADA (Drug) $248.74
- MYDAYIS (Drug) $181.94
- BRINTELLIX (Drug) $147.36
- Auvelity (Drug) $135.38
- NUCALA (Biological) $122.04
- XYREM (Drug) $122.04
- SUNOSI (Drug) $115.15
- Azstarys (Drug) $112.87
- Prolastin-C (Biological) $107.14
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $102.85
- FEVIPIPRANT (Drug) $78.00
- XOLAIR (Biological) $30.40
- APLENZIN (Drug) $25.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Pittsburgh
Sydur Rahman, M.d, M.D
Child & Adolescent Psychiatry — Payments: $1,450
Child & Adolescent Psychiatry $1,450
Dr. Lisa Pan, M.d, M.D
Child & Adolescent Psychiatry — Payments: $256.28
Child & Adolescent Psychiatry $256.28
Miss. Teresa Lutka, Md, MD
Child & Adolescent Psychiatry — Payments: $161.23
Child & Adolescent Psychiatry $161.23
Henry Patrick Driscoll
Child & Adolescent Psychiatry — Payments: $131.89
Child & Adolescent Psychiatry $131.89
Valerie Miller, M.d, M.D
Child & Adolescent Psychiatry — Payments: $124.13
Child & Adolescent Psychiatry $124.13
Rachel Whelan
Child & Adolescent Psychiatry — Payments: $91.31
Child & Adolescent Psychiatry $91.31